Kasia Lipska

Endocrinologist at Yale. Diabetes outcomes researcher.

[Kasia Lipska @klipskaMD]

@Kidfears99 Yes sure, email me at: [email protected]

[Kasia Lipska @klipskaMD]

Recent policies to cap out-of-pocket payments, require rebates on price hikes, & allow government negotiation. From CalRx to federal legislation, the fight for affordable medications! https://t.co/gDySZ3nkk5

[Kasia Lipska @klipskaMD]

@Kidfears99 Lessons From Insulin: Policy Prescriptions for Affordable Diabetes and Obesity Medications https://t.co/gDySZ3nkk5

[Kasia Lipska @klipskaMD]

Lessons From Insulin: Policy Prescriptions for Affordable Diabetes and Obesity Medications https://t.co/gDySZ3nkk5

[Joseph Ross @jsross119]

Friends, colleagues, alumni, please help me spread the word! Applications for the @NationalCSP are due July 15th. Training physicians/PhD nurses to advance health and healthcare for patients and communities through scholarship and action. More info here: https://t.co/KV2G2sjFqD

[Rozalina (Grubina) McCoy, MD MS @RozalinaMD]

So proud of @DavidHJiang for leading this improving work reimagining quality measurement in #diabetes.

We must focus on all domains of quality - effectiveness, equity, efficiency, safety, timeliness - to ensure optimal care & outcomes for all.

[Kasia Lipska @klipskaMD]

Honored to work with @BayleeBakkila and @SanjaybMDPhD on this study. Copay caps are important but $35 per month may still be out of reach to many low income families.

[Kasia Lipska @klipskaMD]

Catastrophic Spending On Insulin In The United States, 2017–18 | Health Affairs Journal https://t.co/RnxB5RIHJB

[JAMA Health Forum @JAMAHealthForum]

Cohort study finds multi-morbidity (esp in young people), prior #hypoglycemia, & #diabetes meds are strongly associated with severe hypoglycemia needing ED/hospital care https://t.co/pcgFOf8bbg @RozalinaMD @klipskaMD @nilaydshah1

[James Elliott @Jandelliott]

New in @JAMAInternalMed "Expensive Insulin—The Epicenter of a Large, Life-Threatening Problem" by @drnallypants @klipskaMD; points out issues in existing out of pocket studies that cause under-estimation of problem https://t.co/AVg7rydjn1 #insulin4all

[Yale Internal Medicine @YaleIMed]

"This study's finding -- that people may be getting drugs in unregulated places -- is a symptom of a failing system. #Insulin & other drugs need to be more affordable for patients," Dr. Kasia Lipska said in https://t.co/dWiPBN2eXm

@usnews @klipskaMD @YaleMed #YaleEndocrinology

[Kasia Lipska @klipskaMD]

Expensive Insulin—The Epicenter of a Large, Life-Threatening Problem https://t.co/YfkVw7uzrQ led by Laura Nally. #insulin4all #t1international

[Kasia Lipska @klipskaMD]

@Kidfears99 We are seeing patients via telehealth or doing phone calls at the Yale Diabetes Center for all routine visits.

[Connecticut #insulin4all @CTinsulin4all]

Reminder that passing #insulin4all legislation NOW is a critical response to #COVID19. Our chapter has seen a huge increase in needs for insulin, diabetes related supplies, and healthcare. Lack of access and high costs were an issue before and have now been magnified.

[Scott Hechinger @ScottHech]

MY GOD: Today’s numbers (March 28, 2020) for Rikers just released by Legal Aid Society. Outbreak spreading exponentially. Now up to 132. The *infection rate is by far the highest in the world.* This is only getting worse. @NYGovCuomo: Release those you promised to release & more.

[Jake Halpern @JakeHalpern]

Introducing the ‘Grandparents’ Academy’ — A way to tap the wisdom and knowledge of our elders and keep our children from losing their minds. (My latest in the NYT) https://t.co/yMgtlVNoJ4

[Kasia Lipska @klipskaMD]

Great opportunity to share comments on how the federal govt could do more for people with diabetes: https://t.co/lqCsGZv7JT

[Dr Jessica Otte, CCFP, FCFP🇨🇦 - palliative/FP @LessIsMoreMed]

On the 4th day of Christmas, my true {evidence sleuthing, critically appraising, unconflicted} L❤️VE gave to meeeeee (& you): challenge the idolatry of the surrogate marker!

See Yukdin @klipskaMD @vmontori https://t.co/jBuijSE4up

#ebm #meded #FOAMed @BCCFP
@UBCMeds @UBCDFP

[kerendo @ker_endo]

Benefits and harms of intensive glycemic control in patients with type 2 diabetes https://t.co/lgCpxJKVrW

[Kasia Lipska @klipskaMD]

@leoebrown Yes! Check out work of T1international https://t.co/x8dHPSHeHT